MDx Firm Transplant Genomics Raises $2.8M | GenomeWeb

NEW YORK (GenomeWeb News) – Molecular diagnostics firm Transplant Genomics has raised $2.8 million toward a targeted $3 million in a private offering, the company said in a document filed with the US Securities and Exchange Commission on Friday.

The firm declined to identify the investors in the round, but a spokesperson said that the funds will be used to commercialize its first product, a test for improving the management of kidney transplant recipients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."